V

Velocity Clinical Research | Lafayette, LA

Research site

(Unclaimed)

Location

401 Youngsville Hwy Suite 100/200B, Lafayette, Louisiana, United States of America

Site insights

Top conditions

Top treatments

Orforglipron

LY3502970

Naltrexone Hydrochloride

Bupropion Hydrochloride

progestin

Obeldesivir

Parent organization

This site is a part of Velocity Clinical Research

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 9 total trials

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040) (ADVANCE)

The purpose of this pediatric, chronic weight management, Phase 3 Master Protocol (PWMP) is to create a framework to evaluate the safety and efficacy...

Enrolling

Overweight

Obesity

Drug: Orforglipron

Drug: Placebo

A Study of Orforglipron (LY3502970) in Adolescent Participants With Obesity, or Overweight With Related Comorbidities

The main purpose of this study, performed under Master Protocol J4M-MC-PWMP, is to evaluate the efficacy, safety, and pharmacokinetics of orforglipro...

Enrolling

Overweight

Obesity

Drug: Orforglipron

Drug: Placebo

Effect of Naltrexone Hydrochloride ER and Bupropion Hydrochloride ER Combination (Contrave®/Mysimba®) on Major Adverse Cardiovascular Events (MACE) (INFORMUS)

A randomized, double-blinded, placebo controlled study intended to capture cardiovascular outcomes during real-world use of naltrexone/bupropion (NB).

Enrolling

Obesity

Drug: Placebo

Drug: Naltrexone-Bupropion (NB) Combination

PK and Safety Study of Natroba Topical Suspension 0.9% in Subjects 1 Month to 3 Years 11 Months of Age with Scabies

A population of approximately 50 pediatric subjects will be enrolled to assess the PK of spinosad and benzyl alcohol for 3 hours following a single,...

Enrolling

Scabies

Drug: Spinosad Topical

Study to Evaluate Contraceptive Efficacy and Safety of a Progestin Only Patch in Women of Childbearing Potential

The Sponsor is developing a progestin-only contraceptive transdermal system (patch).The main purpose of this study is to look at how safe the study p...

Enrolling

Female Contraception

Drug: Transdermal system containing progestin